Novartis Investigative Site

Hot Springs, Arkansas 71913

0 studies enrolling now · 13 studies all time

What they study most

Atherosclerosis, Breast Cancer, Breast Neoplasms, Chronic Heart Failure, Chronic Plaque Type Psoriasis, Erythemato-telangiectatic Rosacea, Moderate to Severe Plaque Psoriasis, Moderate to Severe Plaque-type Psoriasis, Non-Hodgkin's Lymphoma, Plaque Psoriasis, Skeletal Muscle, Thrombocytopaenia

Studies at this site

• Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer — Completed
• Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients — Completed
• Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer — Completed
• Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients — Completed
• A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults — Completed
• Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis — Completed
• First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks — Completed
• Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy — Stopped early
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis — Completed
• A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed